Cargando…
Elevated serum anti-flagellin antibodies implicate subclinical bowel inflammation in ankylosing spondylitis: an observational study
INTRODUCTION: Ankylosing spondylitis (AS) and inflammatory bowel disease (IBD) share genetic and clinical features. IBD is associated with the presence of antibodies to a variety of commensal microorganisms including anti-Saccharomyces cerevesiae antibodies (ASCA), antineutrophil cytoplasmic antibod...
Autores principales: | Wallis, Dinny, Asaduzzaman, Arundip, Weisman, Michael, Haroon, Nigil, Anton, Ammepa, McGovern, Dermot, Targan, Stephan, Inman, Robert |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3978579/ https://www.ncbi.nlm.nih.gov/pubmed/24286190 http://dx.doi.org/10.1186/ar4350 |
Ejemplares similares
-
Markers of intestinal inflammation in patients with ankylosing spondylitis: a pilot study
por: Matzkies, Franziska G, et al.
Publicado: (2012) -
The genetic basis of ankylosing spondylitis: new insights into disease pathogenesis
por: Tsui, Florence WL, et al.
Publicado: (2014) -
Inflammatory bowel disease serologies in ankylosing spondylitis patients: a pilot study
por: Mundwiler, Matthew L, et al.
Publicado: (2009) -
Editorial: Ankylosing Spondylitis and Related Immune-Mediated Disorders
por: Fiorillo, Maria Teresa, et al.
Publicado: (2019) -
Relationship between the gut and the spine: a pilot study of first-degree relatives of patients with ankylosing spondylitis
por: Kehl, Amy S, et al.
Publicado: (2017)